Regulates the use of AI systems in health-care utilization review and prohibits payment for AI-delivered psychotherapy services. Applies to health insurance carriers, pharmacy benefit managers, private utilization review organizations, behavioral health administrative services organizations, and managed care entities that use AI for utilization review. Requires AI systems used in utilization review to base determinations on individual clinical data rather than solely group data, prohibits coverage denials based solely on AI output without human clinical review, and mandates documentation, audit logs, and periodic performance review. Prohibits carriers and Medicaid/CHP+ payers from covering psychotherapy services provided directly by an AI system. Requires written disclosures to applicable state regulatory agencies identifying AI utilization review functions, oversight processes, and audit procedures.